Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for pulmonary function in scleroderma
IRCT2014012616367N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in systemic sclerosis (SSc) and pulmonary fibrosis secondary to systemic sclerosis (SSc-ILD), sponsored by Shiraz University of Medical Sciences. Started Mar 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
systemic sclerosis (SSc)pulmonary fibrosis secondary to systemic sclerosis (SSc-ILD)
Beyond the preview
Go deeper on IRCT2014012616367N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014012616367N1.